Neimeth to Unveil Strategic Plan, Wins Capital Market Award

The Managing Director/ CEO of Neimeth International Pharmaceuticals Plc, Matthew Azoji, has said the company would soon launch a five-year strategic plan to reposition it for greater roles in the healthcare industry and ensure good returns on investment for shareholders and provide services that will delight all stakeholders.

Azoji stated this just as Neimeth recently won the sectoral leadership award for the healthcare (pharmaceuticals) sector of the Nigerian Stock Exchange (NSE) at the 2019 Pearl Awards Limited awards nite. The annual awards ceremony is based on the performance of quoted companies on the Nigerian capital market.

Neimeth came top ahead of two other nominees, all leading pharmaceutical companies quoted on the NSE.

The award was the second of such awards in the capital market to be received by Neimeth this year as Azoji was named among the BusinessDay/Nigerian Stock Exchange top 25 CEOs in Nigeria in recognition of the performance of the company’s shares on the exchange.

According to the Azoji, the Pearl award and others before it are certificates that will motivate the company to strive to do better.

“Our strategic plan is to move Neimeth from a good company to a great company. We shall soon launch a 5-year strategic plan to reposition the company to play greater roles in the healthcare industry, ensure good returns on investment for shareholders and provide services that will delight all stakeholders,” he said. Azoji said.

Neimeth is over 61 years old as a business in Nigeria. It transited from an arm of a foreign transnational, Pfizer Inc. to Neimeth International Pharmaceuticals Plc in May 1997 through a management buyout of the US investors to become a wholly owned indigenous company.